# An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"

> **NCT06815549** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation** · enrollment: 280 (estimated)

## Conditions studied

- P. Aeruginosa
- Baumannii
- Klebsiella Pneumonia
- E.coli Infections
- Enterococcus Faecalis Infection
- Chronic Bacterial Cystitis

## Interventions

- **DRUG:** Fluorothiazinone, tablets 300 mg
- **DRUG:** Nitrofurantoin 100 MG

## Key facts

- **NCT ID:** NCT06815549
- **Lead sponsor:** Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06815549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06815549, "An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06815549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*